New Key Statistics Module, Z-Score and F-Score
NAS:CLGN Key Ratios
Market Cap $ M | 58.99 |
Enterprise Value $ M | 38.78 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | 14.87 |
Price/Book | 2.41 |
Price/Sales | 5.70 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 10.00 |
EPS (TTM) $ | -0.68 |
Beneish M-Score | 8.57 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -4.66 |
EV-to-EBITDA | -5.37 |
PEG | -- |
Shares Outstanding M | 11.45 |
Net Margin (%) | -70.59 |
Operating Margin % | -78.33 |
Pre-tax Margin (%) | -70.59 |
Quick Ratio | 6.96 |
Current Ratio | 7.15 |
ROA % (ttm) | -20.91 |
ROE % (ttm) | -24.81 |
ROIC % (ttm) | -90.59 |
Dividend Yield % | -- |
Altman Z-Score | 1.76 |
CLGN Number of Guru Trades
CLGN Volume of Guru Trades
Gurus Latest Trades with NAS:CLGN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CLGN is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
CollPlant Biotechnologies Ltd Insider Transactions
No Available Data
News about NAS:CLGN
Total 0- 1